Abstract
This paper addresses the adjuvant use and neuromodulatory therapy of cannabis in Alzheimer's. It preliminarily considers the effects and risks of the medicinal use of cannabis, the anticonvulsant effect in epilepsy and the prospects for use in Alzheimer's. He argues for neuromodulatory use in Alzheimer's, in addition to the more restricted use to placate symptoms. And it concludes by pointing to the half-open perspectives and more recent investigations about the neuroprotective character of cannabis.
DOI:https://doi.org/10.56238/globalhealthprespesc-028